The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma

Background Glioblastoma, the most aggressive primary brain tumor, is genetically heterogeneous. Alternative splicing (AS) plays a key role in numerous pathologies, including cancer. The objectives of our study were to determine whether aberrant AS could play a role in the malignant phenotype of glioma and to understand the mechanism underlying its aberrant regulation. Methods We obtained surgical samples from patients with glioblastoma who underwent 5-aminolevulinic fluorescence-guided surgery. Biopsies were taken from the tumor center as well as from adjacent normal-appearing tissue. We used a global splicing array to identify candidate genes aberrantly spliced in these glioblastoma samples. Mechanistic and functional studies were performed to elucidate the role of our top candidate splice variant, BAF45d, in glioblastoma. Results BAF45d is part of the switch/sucrose nonfermentable complex and plays a key role in the development of the CNS. The BAF45d/6A isoform is present in 85% of over 200 glioma samples that have been analyzed and contributes to the malignant glioma phenotype through the maintenance of an undifferentiated cellular state. We demonstrate that BAF45d splicing is mediated by polypyrimidine tract-binding protein 1 (PTBP1) and that BAF45d regulates PTBP1, uncovering a reciprocal interplay between RNA splicing regulation and transcription. Conclusions Our data indicate that AS is a mechanism that contributes to the malignant phenotype of glioblastoma. Understanding the consequences of this biological process will uncover new therapeutic targets for this devastating disease.

[1]  D. Black,et al.  The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation , 2015, eLife.

[2]  Benjamin J. Blencowe,et al.  Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles , 2015, Neuron.

[3]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[4]  D. Scholtens,et al.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. , 2014, The Journal of clinical investigation.

[5]  Á. Rubio,et al.  Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. , 2014, Cancer research.

[6]  R. Scienza,et al.  Phenotypic and functional characterization of Glioblastoma cancer stem cells identified trough 5-aminolevulinic acid-assisted surgery , 2014, Journal of Neuro-Oncology.

[7]  Jian Zhang,et al.  Misregulation of pre-mRNA alternative splicing in cancer. , 2013, Cancer discovery.

[8]  Bartolomé Bejarano,et al.  Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery. , 2013, Neurosurgery.

[9]  G. Crabtree,et al.  From neural development to cognition: unexpected roles for chromatin , 2013, Nature Reviews Genetics.

[10]  Yi Zhang,et al.  Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits , 2013, Cell.

[11]  Michael D. Wilson,et al.  The Evolutionary Landscape of Alternative Splicing in Vertebrate Species , 2012, Science.

[12]  Ahmed Sadeque,et al.  Identification and characterization of alternative exon usage linked glioblastoma multiforme survival , 2012, BMC Medical Genomics.

[13]  R. Krahe,et al.  PTBP1‐dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis , 2012, Molecular carcinogenesis.

[14]  M. Idoate,et al.  Pathological characterization of the glioblastoma border as shown during surgery using 5‐aminolevulinic acid‐induced fluorescence , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[15]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[16]  Ross Smith,et al.  Functional diversity of the hnRNPs: past, present and perspectives. , 2010, The Biochemical journal.

[17]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[18]  Gene W. Yeo,et al.  Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. , 2009, Molecular cell.

[19]  Wen Zhu,et al.  Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. , 2009, Brain : a journal of neurology.

[20]  K. Baggerly,et al.  Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays , 2008, BMC Genomics.

[21]  V. Buchman,et al.  Generation of mutant mice with targeted disruption of two members of the d4 gene family: neuro-d4 and cer-d4 , 2008, Doklady Biochemistry and Biophysics.

[22]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[23]  M. J. van den Bent,et al.  Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. , 2007, Cancer research.

[24]  B. Frey,et al.  Functional coordination of alternative splicing in the mammalian central nervous system , 2007, Genome Biology.

[25]  William Stafford Noble,et al.  Quantifying similarity between motifs , 2007, Genome Biology.

[26]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[27]  M. Gorospe,et al.  Identification of a target RNA motif for RNA-binding protein HuR. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Jin,et al.  Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion. , 2003, Cancer research.

[29]  G. Fuller,et al.  An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.

[30]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.

[31]  J. G. Patton,et al.  Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. , 1991, Genes & development.

[32]  Amy E. Hawkins,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2022 .

[33]  G. Crabtree,et al.  MicroRNA-mediated switching of chromatin-remodelling complexes in neural development , 2009, Nature.

[34]  W. Jin,et al.  Advances in Brief Polypyrimidine Tract-Binding Protein Down-Regulates Fibroblast Growth Factor Receptor 1-Exon Inclusion 1 , 2003 .